Greg Hunt
DIRECTOR OF DERMATOLOGICAL DEVICES
Corona del Mar,CA
Summary
Results-driven operations executive with 20 years of expertise in optimizing production processes, supply chain efficiency, and product development lifecycles. Extensive leadership experience across manufacturing, quality, and regulatory compliance sectors. Skilled at navigating complex regulatory environments while maintaining operational excellence. Recognized for building high-performing teams and implementing continuous improvement initiatives. Accomplished business strategist with proven success in scaling operations, reducing costs, and driving sustainable growth through data-driven decision-making.
Overview
16
16
years of professional experience
Work History
Director of Dermatological Devices
Golden Hippo
- 01.2025
- Strategic sourcing of Class II OTC photobiomodulation devices, quality management, regulatory compliance, and distribution within a QMSR/ISO 13485 framework using Deposco WMS, NetSuite ERP, and Salesforce CRM; CSCP (enrolled/in process)
- Selected Achievements:
- Spearheaded inventory, operational, and regulatory readiness for human and pet device launches.
- Implemented eQMS (Qualio) and SOPs for AEs, complaint handling, IQC, recalls, and traceability.
- Achieved 84% gross margin on low MOQs.
- Compliance testing of finished goods enabling air freight for Dangerous Goods from northern China.
VP, Operations, Quality, and Regulatory
Joylux, Inc.
- 01.2024
- Orchestrate comprehensive operational strategies for medical device manufacturing and quality management systems. Supervise international supply chain operations across American and Chinese contract manufacturers. Administer Person Responsible for Regulatory Compliance (PRRC) duties including ISO 13485 and MDSAP audits. Manage multi-channel logistics operations encompassing air freight, B2B, D2C, customs, drop-ship, international logistics, LCL, LTL, MABDs, ocean freight.
- Selected Achievements:
- Spearheaded operational readiness for cosmetic and device launches with Halle Berry/RESPIN and Essity/Issviva.
- Advanced and updated QMS SOPs for CAPAs, complaint handling, ECOs, NCMRs, RCA, and SCARs.
- Achieved a 510(k) clearance from a third party reviewer by leveraging new bridging data.
Vice President of Operations and Combination Product Development
University Medical Pharmaceuticals Corp.
01.2014 - 01.2023
- Directed development initiatives for innovative dissolvable microneedle array technologies and manufacturing processes. Established strategic partnerships with Key Opinion Leaders in drug delivery and infectious disease sectors. Generated preclinical testing protocols supporting patent applications. Pioneered new OTC pharmaceutical product development strategies.
- Selected Achievements:
- Achieved $35MM revenue growth in 9 months through development of new OTC antibacterial and antiseptic product lines.
- Secured acceptance into University Lab Partners MedTech incubator at UC Irvine.
- Demonstrated successful preclinical proof of concept supporting provisional patent filings.
- Developed ground-breaking dissolvable microneedle array compositions.
Vice President of Operations and Product Development
University Medical Pharmaceuticals Corp.
01.2012 - 01.2014
- Steered cross-functional operations including contract manufacturing, formulation, packaging, quality, regulatory affairs, and supply chain for WrinkleMD brand. Engineered development of proprietary dermal delivery systems. Led commercialization efforts targeting premium retail channels. Facilitated patent development and submission processes.
- Selected Achievements:
- Secured two granted patents for novel active diffusion dermal delivery system.
- Generated $1MM+ revenue through expansion into Bloomingdales, Harrods, Nordstrom, and Ulta.
- Co-engineered innovative active diffusion dermal delivery system.
Vice President of Operations
University Medical Pharmaceuticals Corp.
01.2007 - 01.2012
- Commanded end-to-end operational excellence initiatives spanning manufacturing, distribution, and supply chain optimization. Launched automated inventory management systems including bin locations and random cycle counting. Instituted project management frameworks for new product introductions. Guided strategic planning for company valuation and acquisition.
- Selected Achievements:
- Delivered $4.3MM annual cost reduction through formulation reverse engineering.
- Accelerated revenue growth from $25MM to $75MM over a 5-year period.
- Implemented distribution center operations generating $1M+ annual freight savings.
- Leveraged EDI 830 and work orders for continuous improvement of KPIs and supplier scorecards.
- Generated acquisition bids exceeding $200MM and achieved 33% ($16MM) purchase price increase.
Education
Master of Business Administration - MBA
Claremont Graduate University
Claremont, CAMaster of Science - Earth Science
San Jose State University
San Jose, CABachelor of Science - Earth Science
San Jose State University
San Jose, CAAccomplishments
- Accelerated company revenue growth by 300% from $25MM to $75MM in five years through supply chain optimization and automated inventory management.
- Generated $4.3MM annual cost savings through strategic formulation reverse-engineering and enhanced supply chain resilience.
- Delivered $35MM revenue growth in 9 months by developing and launching new OTC antibacterial and antiseptic product lines.
- Secured acquisition bids exceeding $200MM and negotiated 33% purchase price increase of $16MM through operational excellence initiatives.
- Expanded market presence by establishing partnerships with Fortune 50 retailers including Bloomingdales, Harrods, Nordstrom, and Ulta, generating $1MM+ in new revenue.
Publications
- Microneedle devices for delivery of mRNA pharmaceuticals, and methods of manufacturing microneedle devices | U.S. Provisional Application No.: 63/351,501 | 2022
- Microneedle devices for delivery of bioactive agents, and methods of manufacturing microneedle devices | U.S. Provisional Application No.: 63/332,296 | 2022
- Process and system for iontophoretic wrinkle reduction | US 9913977B2 | 2018
- Process and system for iontophoretic wrinkle reduction | US8747383A2 | 2014
Timeline
Vice President of Operations and Combination Product Development
University Medical Pharmaceuticals Corp.
01.2014 - 01.2023
Vice President of Operations and Product Development
University Medical Pharmaceuticals Corp.
01.2012 - 01.2014
Vice President of Operations
University Medical Pharmaceuticals Corp.
01.2007 - 01.2012
Director of Dermatological Devices
Golden Hippo
- 01.2025
VP, Operations, Quality, and Regulatory
Joylux, Inc.
- 01.2024
Master of Business Administration - MBA
Claremont Graduate University
Master of Science - Earth Science
San Jose State University
Bachelor of Science - Earth Science
San Jose State University
Similar Profiles
Missy GurgaMissy Gurga
Retail Marketing Manager at Golden HippoRetail Marketing Manager at Golden Hippo
Kaitlyn MedinaKaitlyn Medina
Retail/E-commerce Coordinator at Golden HippoRetail/E-commerce Coordinator at Golden Hippo
Greg HuntGreg Hunt
Director of Dermatological Devices at Golden HippoDirector of Dermatological Devices at Golden Hippo
ADONIS CARRADONIS CARR
Web Support II at Golden Bolt LLC / Golden HippoWeb Support II at Golden Bolt LLC / Golden Hippo
Ann LewisAnn Lewis
Design Consultant at 3 Day BlindsDesign Consultant at 3 Day Blinds